NDC 85237-1871-01 - Excedrin Migraine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85237-1871
- Requested NDC
- 85237-1871-01
- Package NDCs from labels
- 85237-1871-1, 85237-1871-2, 85237-1871-3, 85237-1871-4, 85237-1871-0, 85237-1871-7, 85237-1871-01
- Manufacturer
- Select Consumer Group
- Effective date
- 2026-10-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Excedrin Migraine - Select Consumer Group | Select Consumer Group | 2026-10-24 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85237-1871-1 | ExcedrinMigraine | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 2 | |
| 85237-1871-1 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-2 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-2 | ExcedrinMigraine | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-3 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 | |
| 85237-1871-3 | ExcedrinMigraine | 25 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 25 | 2 | |
| 85237-1871-4 | ExcedrinMigraine | 50 in 1 BOX, UNIT-DOSE | TABLET, FILM COATED | 50 | 2 | |
| 85237-1871-4 | ExcedrinMigraine | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dual Action Pain Relief | DUAL ACTION PAIN RELIEF | Allegiant Health | fb4fc347-0f90-429f-9ca8-903e736f5496 | 2024-03-29 | Warnings | 362O9ITL9D |
| RV Illuminance Serum Tint Broad Spectrum 15 | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 132aab60-da19-7079-e063-6394a90a1d76 | 2024-03-27 | Warnings | 15FIX9V2JP |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | c8d65aab-d6ae-bc69-e053-2a95a90a7b5e | 2024-03-27 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| ANTIGRIP Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Pharmadel LLC | 12de30fd-95b6-f16d-e063-6294a90aeba2 | 2024-03-27 | Warnings | 362O9ITL9D |
| RV Illuminance Serum Tint Broad Spectrum 15 Amber | FACE FOUNDATION WITH SPF | REVLON CONSUMER PR Consumer Products Corp | 2a0ac71c-e53a-5ff9-e063-6394a90a4807 | 2024-03-27 | Warnings | 15FIX9V2JP |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Family Dollar (FAMILY WELLNESS) | 0044c53c-11dd-41a9-a5d9-622dd8b1c144 | 2024-03-27 | Warnings | 362O9ITL9D |
| EltaMD UV Pure SPF47 | ZINC OXIDE AND TITANIUM DIOXIDE SUNSCREEN | CP Skin Health Group, Inc. | 9afe900b-4186-4189-a871-ad6f26fc26e4 | 2024-03-27 | Warnings | 15FIX9V2JP |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | 650cb15e-c448-4df3-b0f8-4398be05d841 | 2024-03-27 | Warnings | 308297 3G6A5W338E R16CO5Y76E 362O9ITL9D |
| Good Sense Effervescent Pain Relief | ASPIRIN | Perrigo Direct, Inc. | 103027a7-2f0e-8d8c-e063-6294a90aedc7 | 2024-03-26 | Warnings | R16CO5Y76E |
| Envirotox | TRITICUM AESTIVUM, BERBERIS VULGARIS, LAPPA MAJOR, RHAMNUS PURSHIANA, SENNS (CASSIA ANGUSTIFOLIA), PHYTOLACCA DECANDRA, GLYCYRRHIZA GLABRA, STILLINGIA SYLVATICA, TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, ACETONUM ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM, BELLADONNA, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM. | BioActive Nutritional, Inc. | 2b5cfdba-cf4d-4eb0-8c60-20eac6922663 | 2024-03-26 | Warnings | 6DC9Q167V3 |
| rugby infants acetaminophen | ACETAMINOPHEN | Rugby Laboratories | 8aa9ac68-ca61-4163-a876-52034138c1ea | 2024-03-25 | Warnings | 362O9ITL9D |
| SPF 50 Mineral Based Facial Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Hutton, Kathleen MD | 5cf0d2e3-d496-424c-ac75-70ff5b87e9ca | 2024-03-25 | Warnings | 15FIX9V2JP |
| Equate Pain Reliever Acetaminophen for Adults 250 mg | ACETAMINOPHEN | Walmart Inc | 08a18481-f029-f01f-e063-6294a90aac65 | 2024-03-21 | Warnings | 362O9ITL9D |
| Equate Pain Reliever Acetaminophen for Adults 250 mg | ACETAMINOPHEN | Walmart Inc | 0d106fa2-2a77-deb2-e063-6394a90a2dac | 2024-03-21 | Warnings | 362O9ITL9D |
| Daily Prevention Advanced Smartblend Mineral Moisturizer SPF 75 | TITANIUM DIOXIDE AND ZINC OXIDE | Allure Labs | 141bb721-cd1c-5bba-e063-6394a90ab8fa | 2024-03-20 | Warnings | 15FIX9V2JP |
| Sunscreen-Lotion | ZINC OXIDE, TITANIUM DIOXIDE | Shanghai Chuangshi Medical Technology (Group) Co., Ltd. | 0511ff57-b7bd-4708-e063-6294a90a58a8 | 2024-03-20 | Warnings | 15FIX9V2JP |
| Acetaminophen | ACETAMINOPHEN TABLET EXTENDED RELEASE | TIME CAP LABORATORIES, INC. | cd4d0ad4-7206-94c8-e053-2a95a90aaa14 | 2024-03-19 | Warnings | 362O9ITL9D |
| Cold and Flu Relief Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 06d47104-a8ca-48cc-b27e-08c9d018c37b | 2024-03-19 | Warnings | 362O9ITL9D |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | b80dae7f-ed2d-4a9e-bef9-f1ed8add0174 | 2024-03-19 | Warnings | 362O9ITL9D |
| Good Sense Dual Action Back Pain | ACETAMINOPHEN, IBUPROFEN | L. Perrigo Company | 89476188-cf88-4184-a366-ed4c2e7db145 | 2024-03-19 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.